Analyst Ratings For FibroGen (NASDAQ:FGEN)
Today, Leerink Swann reiterated its Outperform rating on FibroGen (NASDAQ:FGEN) with a price target of $88.00.
Some recent analyst ratings include
- 2/28/2018-Leerink Swann Reiterated Rating of Outperform.
- 11/9/2017-Mizuho Reiterated Rating of Hold.
- 9/14/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 9/12/2017-Jefferies Group Reiterated Rating of Buy.
- 8/9/2017-William Blair Reiterated Rating of Outperform.
- 7/21/2017-Goldman Sachs Group was Downgraded by analysts at Goldman Sachs Group from a “Buy ” rating to a ” Neutral” rating. They now have a $31.00 price target on the stock.
Recent Insider Trading Activity For FibroGen (NASDAQ:FGEN)
FibroGen (NASDAQ:FGEN) has insider ownership of 13.60% and institutional ownership of 59.24%.
- On 2/23/2018 Thomas B Neff, CEO, sold 39,636 with an average share price of $56.66 per share and the total transaction amounting to $2,245,775.76.
- On 2/16/2018 Pat Cotroneo, VP, sold 49,500 with an average share price of $55.96 per share and the total transaction amounting to $2,770,020.00.
- On 2/15/2018 Kalevi Kurkijarvi, Director, sold 6,000 with an average share price of $55.69 per share and the total transaction amounting to $334,140.00.
- On 2/8/2018 K Peony Yu, Insider, sold 7,500 with an average share price of $53.97 per share and the total transaction amounting to $404,775.00.
- On 1/30/2018 Thomas B Neff, CEO, sold 38,636 with an average share price of $61.40 per share and the total transaction amounting to $2,372,250.40.
- On 1/29/2018 K Peony Yu, Insider, sold 10,000 with an average share price of $62.00 per share and the total transaction amounting to $620,000.00.
- On 1/26/2018 Roberto Pedro Rosenkranz, Director, sold 6,000 with an average share price of $60.00 per share and the total transaction amounting to $360,000.00.
Recent Trading Activity for FibroGen (NASDAQ:FGEN)
Shares of FibroGen closed the previous trading session at 55.15 down -3.30 5.65% with 199816 shares trading hands.
